Compare EEIQ & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EEIQ | NCNA |
|---|---|---|
| Founded | 2017 | 1997 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1M | 7.6M |
| IPO Year | 2021 | 2017 |
| Metric | EEIQ | NCNA |
|---|---|---|
| Price | $0.29 | $3.69 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 62.1K | ★ 65.1K |
| Earning Date | 01-30-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $9,358,301.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 44.99 | N/A |
| 52 Week Low | $0.23 | $2.78 |
| 52 Week High | $1.74 | $330.00 |
| Indicator | EEIQ | NCNA |
|---|---|---|
| Relative Strength Index (RSI) | 33.01 | 43.41 |
| Support Level | $0.33 | $4.10 |
| Resistance Level | $0.35 | $4.55 |
| Average True Range (ATR) | 0.02 | 0.28 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 21.00 | 0.00 |
EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S., Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. Company operated in three primary reportable segments foreign language education (QHI), foreign language education (RIL) and the professional training programs.
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.